-
4
-
-
84961308135
-
-
P.R. Moore, A. Evenson, T.D. Luckey, E. McCoy, C.A. Elvehjem, and E.B. Hart J. Biol. Chem. 165 1946 437 441
-
(1946)
J. Biol. Chem.
, vol.165
, pp. 437-441
-
-
Moore, P.R.1
Evenson, A.2
Luckey, T.D.3
McCoy, E.4
Elvehjem, C.A.5
Hart, E.B.6
-
5
-
-
0036242821
-
-
A. Carta, G. Paglietti, M.E.R. Nikookar, P. Sanna, L. Sechi, and S. Zanetti Eur. J. Med. Chem. 37 2002 355 366
-
(2002)
Eur. J. Med. Chem.
, vol.37
, pp. 355-366
-
-
Carta, A.1
Paglietti, G.2
Nikookar, M.E.R.3
Sanna, P.4
Sechi, L.5
Zanetti, S.6
-
7
-
-
77956651007
-
-
S. Ancizu, E. Moreno, B. Solano, R. Villar, A. Burguete, E. Torres, S. Pérez-Silanes, I. Aldana, and A. Monge Bioorg. Med. Chem 18 2010 (ASAP)
-
(2010)
Bioorg. Med. Chem
, vol.18
-
-
Ancizu, S.1
Moreno, E.2
Solano, B.3
Villar, R.4
Burguete, A.5
Torres, E.6
Pérez-Silanes, S.7
Aldana, I.8
Monge, A.9
-
8
-
-
65549122012
-
-
U. Das, H.N. Pati, A.K. Panda, E. De Clercq, J. Balzarini, J. Molnár, Z. Baráth, I. Ocsovszki, M. Kawase, L. Zhou, H. Sakagami, and J.R. Dimmock Bioorg. Med. Chem. 17 2009 3909 3915
-
(2009)
Bioorg. Med. Chem.
, vol.17
, pp. 3909-3915
-
-
Das, U.1
Pati, H.N.2
Panda, A.K.3
De Clercq, E.4
Balzarini, J.5
Molnár, J.6
Baráth, Z.7
Ocsovszki, I.8
Kawase, M.9
Zhou, L.10
Sakagami, H.11
Dimmock, J.R.12
-
10
-
-
33746883227
-
-
D. Aparicio, O.A. Attanasi, P. Filippone, R. Ignacio, S. Lillini, F. Mantellini, F. Palacios, and J.M. De Ios Santos J. Org. Chem. 71 2006 5897 5905
-
(2006)
J. Org. Chem.
, vol.71
, pp. 5897-5905
-
-
Aparicio, D.1
Attanasi, O.A.2
Filippone, P.3
Ignacio, R.4
Lillini, S.5
Mantellini, F.6
Palacios, F.7
De Ios Santos, J.M.8
-
12
-
-
34548548357
-
-
M. Teng, M.D. Johnson, C. Thomas, D. Kiel, J.N. Lakis, T. Kercher, S. Aytes, J. Kostrowicki, D. Bhumralkar, L. Truesdale, J. May, U. Sidelman, J.T. Kodra, A.S. Jorgensen, P.H. Olesen, J. Cornelis de Jong, P. Madsen, C. Behrens, I. Pettersson, L.B. Knudsen, J.J. Holst, and J. Lau Biorg. Med. Chem. Lett. 17 2007 5472 5478
-
(2007)
Biorg. Med. Chem. Lett.
, vol.17
, pp. 5472-5478
-
-
Teng, M.1
Johnson, M.D.2
Thomas, C.3
Kiel, D.4
Lakis, J.N.5
Kercher, T.6
Aytes, S.7
Kostrowicki, J.8
Bhumralkar, D.9
Truesdale, L.10
May, J.11
Sidelman, U.12
Kodra, J.T.13
Jorgensen, A.S.14
Olesen, P.H.15
Cornelis De Jong, J.16
Madsen, P.17
Behrens, C.18
Pettersson, I.19
Knudsen, L.B.20
Holst, J.J.21
Lau, J.22
more..
-
13
-
-
77956651487
-
-
U.S. Patent 51,18,675
-
Jirkovsky, I. L.; Baudy, R. B.; Greenblatt, L. P. U.S. Patent 51,18,675, 1992
-
(1992)
-
-
Jirkovsky, I.L.1
Baudy, R.B.2
Greenblatt, L.P.3
-
14
-
-
0032478159
-
-
P. Acklin, H. Allgeier, Y.P. Auberson, S. Bischoff, S. Ofner, D. Sauer, and M. Schmutz Bioorg. Med. Chem. Lett. 8 1998 493 498
-
(1998)
Bioorg. Med. Chem. Lett.
, vol.8
, pp. 493-498
-
-
Acklin, P.1
Allgeier, H.2
Auberson, Y.P.3
Bischoff, S.4
Ofner, S.5
Sauer, D.6
Schmutz, M.7
-
19
-
-
0345265140
-
-
M.M. El-Abadelah, A.A. Anani, Z.H. Khan, A.M. Hassan, and A. Katrib J. Heterocycl. Chem. 17 1980 1671
-
(1980)
J. Heterocycl. Chem.
, vol.17
, pp. 1671
-
-
El-Abadelah, M.M.1
Anani, A.A.2
Khan, Z.H.3
Hassan, A.M.4
Katrib, A.5
-
20
-
-
77956648935
-
-
note
-
5P, 374.1032, found 374.1024.
-
-
-
-
21
-
-
49149093202
-
-
The utilization of LiHMDS has been recommended for the preparation of lithium salts from P-H bonds, see: Y. Belabassi, M.I. Antczak, J. Tellez, and J.-L. Montchamp Tetrahedron 64 2008 9181 9190
-
(2008)
Tetrahedron
, vol.64
, pp. 9181-9190
-
-
Belabassi, Y.1
Antczak, M.I.2
Tellez, J.3
Montchamp, J.-L.4
-
22
-
-
77956652669
-
-
On treating 2-chloroquinoxaline monoxide with an excess of CsF and [18:6] crown ether in THF at room temperature for 16 h, we obtained a crude mixture containing about 50% of the quite unstable 2-fluoroquinoxaline monoxide
-
On treating 2-chloroquinoxaline monoxide with an excess of CsF and [18:6] crown ether in THF at room temperature for 16 h, we obtained a crude mixture containing about 50% of the quite unstable 2-fluoroquinoxaline monoxide.
-
-
-
-
23
-
-
77956647743
-
-
Experiments run without adding HI resulted in no conversion into 2-iodoquinoxaline monoxide. This latter compound has already been prepared, albeit in lower yield, by thermal decomposition of the corresponding 2-diazonium fluoroborate (Balz-Schiemann reaction)
-
Experiments run without adding HI resulted in no conversion into 2-iodoquinoxaline monoxide. This latter compound has already been prepared, albeit in lower yield, by thermal decomposition of the corresponding 2-diazonium fluoroborate (Balz-Schiemann reaction).
-
-
-
-
24
-
-
50449107901
-
-
2/dppf, as recently precognized for the synthesis of heteroarylphosphonates by Hirao cross-coupling: Y. Belabassi, S. Alzghari, and J.-L. Montchamp J. Organomet. Chem. 693 2008 3171 3178 Switching dppf to xantphos doubled the yield of the reaction
-
(2008)
J. Organomet. Chem.
, vol.693
, pp. 3171-3178
-
-
Belabassi, Y.1
Alzghari, S.2
Montchamp, J.-L.3
-
29
-
-
77956652834
-
-
Subjecting phosphonate 13a to treatment in methanol in the presence of molecular sieves under reaction conditions yielded a complete conversion into 2-methyl-quinoxaline 1,4-di-N-oxide 12
-
Subjecting phosphonate 13a to treatment in methanol in the presence of molecular sieves under reaction conditions yielded a complete conversion into 2-methyl-quinoxaline 1,4-di-N-oxide 12.
-
-
-
-
30
-
-
77956651467
-
-
3, or MeOH
-
3, or MeOH.
-
-
-
-
31
-
-
77956650331
-
-
The reaction appeared quite sluggish in the case of R = iPr or cyclopropyl: we observed in NMR on prolonged reaction time a complex mixture containing less than 15% of the desired phosphonate
-
The reaction appeared quite sluggish in the case of R = iPr or cyclopropyl: we observed in NMR on prolonged reaction time a complex mixture containing less than 15% of the desired phosphonate.
-
-
-
|